E523-0807 Screening compound: N~1~-[3-(butylsulfanyl)propyl]-4-[6-oxopyrido[2,3-b][1,4]benzothiazepin-5(6H)-yl]butanamide

E523-0807 Screening compound: N~1~-[3-(butylsulfanyl)propyl]-4-[6-oxopyrido[2,3-b][1,4]benzothiazepin-5(6H)-yl]butanamide
E523-0807 Screening compound: N~1~-[3-(butylsulfanyl)propyl]-4-[6-oxopyrido[2,3-b][1,4]benzothiazepin-5(6H)-yl]butanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E523-0807
N~1~-[3-(butylsulfanyl)propyl]-4-[6-oxopyrido[2,3-b][1,4]benzothiazepin-5(6H)-yl]butanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E523-0807

Molecular Formula

C23H29N3O2S2 (C23 H29 N3 O2 S2)

Compound Name

N~1~-[3-(butylsulfanyl)propyl]-4-[6-oxopyrido[2,3-b][1,4]benzothiazepin-5(6H)-yl]butanamide

IUPAC name

N-[3-(butylsulfanyl)propyl]-4-{10-oxo-2-thia-49-diazatricyclo[9.4.0.0^{38}]pentadeca-1(11)3571214-hexaen-9-yl}butanamide

SMILES

CCCCSCCCNC(CCCN(c1cccnc1Sc1c2cccc1)C2=O)=O

InChI

InChI=1S/C23H29N3O2S2/c1-2-3-16-29-17-8-14-24-21(27)12-7-15-26-19-10-6-13-25-22(19)30-20-11-5-4-9-18(20)23(26)28/h4-6,9-11,13H,2-3,7-8,12,14-17H2,1H3,(H,24,27)

InChI Key

GIBZTVGEEXRFFB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14894683

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

443.63

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

3.251

Distribution Coefficient, logD

3.251

Water Solubility, LogSw

-3.68

Polar Surface Area

51.016

Acid Dissociation Constant (pKa)

15.52

Base Dissociation Constant (pKb)

1.37

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

43.50

E523-0807 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

Allosteric Kinases Inhibitors Library (23117 compounds)

Antiviral Library (67538 compounds)

Protein-Protein Interaction Library (218420 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Recognition Elements PPI Library (24135 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Mimetics
Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators

References: we are preparing a list of scientific research reports with E523-0807 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E523-0807?
Check Price and Availability of E523-0807, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E523-0807 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E523-0807
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E523-0807
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E523-0807 available by request